MedPath

BAYLOR COLLEGE OF MEDICINE

BAYLOR COLLEGE OF MEDICINE logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Established
1900-10-30
Employees
10K
Market Cap
-
Website
http://www.bcm.edu

Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma

Phase 1
Completed
Conditions
Neuroblastoma
Interventions
Procedure: Skin Biopsy
Genetic: Gene Modified Neuroblastoma Cells
First Posted Date
2003-06-18
Last Posted Date
2012-10-29
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
9
Registration Number
NCT00062855
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

Valacyclovir in Immunocompromised Children

Phase 1
Completed
Conditions
Shingles
Bone Marrow Transplantation
Interventions
First Posted Date
2003-04-30
Last Posted Date
2020-03-04
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
37
Registration Number
NCT00059592
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells

Phase 1
Completed
Conditions
Chronic Lymphocytic B-Leukemia
First Posted Date
2003-04-15
Last Posted Date
2012-05-23
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
9
Registration Number
NCT00058786
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Phase 1
Terminated
Conditions
Hodgkin Disease
Non-Hodgkins Lymphoma
Interventions
Drug: Infusion of EBV Specific Cytotoxic T-Lymphocytes
First Posted Date
2003-04-15
Last Posted Date
2012-11-06
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
5
Registration Number
NCT00058773
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts

Phase 1
Completed
Conditions
Epstein-Barr Virus Infections
Interventions
Biological: EBV specific T cells
First Posted Date
2003-04-15
Last Posted Date
2015-01-29
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
69
Registration Number
NCT00058812
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Houston Methodist Hospital, Houston, Texas, United States

Stem Cell Transplant for Hematologic Diseases

Phase 1
Terminated
Conditions
Hematologic Malignancies
Interventions
Biological: Campath 1H
Drug: Fludarabine
Procedure: Stem Cell Transplant
Radiation: Total Body Irradiation (TBI)
Drug: FK506 (Tacrolimus) or Cyclosporine
First Posted Date
2003-04-15
Last Posted Date
2016-11-06
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
27
Registration Number
NCT00058825
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine

Phase 1
Completed
Conditions
Leukemia
Interventions
Biological: Dose Level 3
Biological: Dose Level 1
Biological: Dose Level 2
First Posted Date
2003-04-15
Last Posted Date
2020-01-21
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
11
Registration Number
NCT00058799
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital GCRC, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)

Phase 1
Completed
Conditions
Epstein-Barr Virus Infections
Interventions
Biological: Intravenous injection of EBV specific CTLS
First Posted Date
2003-04-09
Last Posted Date
2020-01-18
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
13
Registration Number
NCT00058591
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).

Phase 1
Completed
Conditions
Epstein-Barr Virus Infections
Lymphoproliferative Disorders
Interventions
Biological: Intravenous injection of EBV specific CTLs
First Posted Date
2003-04-09
Last Posted Date
2020-01-18
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
12
Registration Number
NCT00058604
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

Stem Cell Transplant to Treat Patients With Systemic Sclerosis

Phase 1
Completed
Conditions
Systemic Sclerosis
First Posted Date
2003-04-09
Last Posted Date
2020-01-18
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
24
Registration Number
NCT00058578
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Methodist Hospital, Houston, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath